•
Jun 30, 2024

ImmunityBio Q2 2024 Earnings Report

Total Revenue
$1.05M
Previous year: $41K
+2453.7%
EPS
-$0.2
Previous year: -$0.32
-37.5%
Gross Profit
-$3.36M
Previous year: -$6.28M
-46.5%
Cash and Equivalents
$218M
Previous year: $43.5M
+401.0%
Free Cash Flow
-$101M
Previous year: -$88.3M
+14.5%
Total Assets
$444M
Previous year: $291M
+52.6%

ImmunityBio

ImmunityBio

ImmunityBio Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income